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Although leptospirosis, a bacterial zoonosis, is responsible for ≈1 million cases per year world-
wide, estimates of its incidence in Africa are limited 
by a lack of quality-assured studies (1). Humans be-
come infected through mucosal membranes or skin 
breaks by direct contact with reservoir animals or ex-
posure to urine-contaminated soil or water. We de-
scribe an outbreak of leptospirosis in prison inmates 
in Cape Town, South Africa, and identification of 
probable animal sources and environmental routes 
of infection.
In September 2015, the South Africa Department 
of Correctional Services requested the National Insti-
tute for Communicable Diseases to assist with investi-
gation and management of leptospirosis infections in 2 
inmates at a maximum-security prison in Cape Town. 
The National Health Laboratory Service Animal Eth-
ics Committee clearance 131/11 granted approval for 
rodent trapping and testing; ethical clearance certifi-
cate no. M160667 from the Human Research Ethics 
Committee (Medical) of the University of the Witwa-
tersrand covered the outbreak investigation.
Case-patient 1, a 52-year-old man, was admit-
ted to a hospital in Cape Town. He had jaundice, 
overwhelming sepsis, disseminated intravascular 
Leptospirosis is a neglected zoonotic disease. In 2015, 
leptospirosis was diagnosed in 2 prison inmates in South 
Africa. Using real-time PCR and DNA sequencing, we 
identified Leptospira interrogans serogroup Icterohaem-
orrhagiae in rodents and water samples within the pris-
on. Leptospirosis might be frequently underdiagnosed in 
South Africa.
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coagulation, and multiorgan failure after ≈1 week of 
worsening illness that included conjunctivitis, my-
algia, and fever. At admission, his leukocyte count 
was 18.64 × 109 cells/L (reference 4–10 × 109 cells/L), 
platelets 65 × 109/L (reference 137–373 × 109/L), total 
bilirubin 30.23 mg/dL (reference 0–1.23 mg/dL) (91% 
conjugated), alanine transaminase 95 U/L (reference 
5–40 U/L), and creatinine 10 mg/dL (reference 0.72–
1.18 mg/dL). He died the following day.
Case-patient 2, a 49-year-old man occupying the 
same prison cell as case-patient 1, was hospitalized 10 
days later. He had jaundice, abdominal pain, anorex-
ia, weakness, and body aches. The initial leukocyte 
count was 21.71 × 109 cells/L, platelets 100 × 109/L, 
total bilirubin 17.89 mg/dL (88% conjugated), alanine 
transaminase 66 U/L, and creatinine 4.66 mg/dL. 
The patient received treatment and was discharged 
after 9 days of hospital stay.
A physician diagnosed leptospirosis on the basis 
of clinical signs and clinical pathology consistent with 
severe leptospirosis (leukocytosis, thrombocytopenia, 
hyperbilirubinemia, mild transaminasemia, acute 
renal failure). For both patients, blood cultures and 
hepatitis virus tests were negative. However, IgM to 
Leptospira spp. was detected by the Panbio Leptospira 
IgM ELISA (Standard Diagnostics, https://www.
alere.com), confirming the clinical diagnosis. The ref-
erence serologic method (microagglutination test) is 
not available in South Africa, and neither blood nor 
urine samples were available for subsequent analysis 
by the reference laboratory.
An initial assessment of the prison by the National 
Institute for Communicable Diseases outbreak inves-
tigation team, together with provincial and national 
Department of Health officials, identified conditions 
favorable for Leptospira transmission (rodent infesta-
tion, standing water, and food waste accumulation). 
Within 3 weeks after hospital admission of case-pa-
tient 2, 12 Rattus norvegicus rats, identified by mor-
phologic characteristics, were live-trapped around 
the prison section housing the patients and humanely 
euthanized, and their kidneys were harvested. Five 
stagnant drain water samples were collected in the 
same area.
We extracted DNA from rodent kidney samples 
using the QIAamp DNA Mini kit on a QIAcube sys-
tem (QIAGEN, https://www.qiagen.com) and from 
water samples using ZR Soil Microbe DNA MicroPrep 
kit (Zymo Research, https://www.zymoresearch.
com). We detected Leptospira DNA with an Applied 
Biosystems 7500 qPCR instrument (Applied Biosys-
tems, https://www.thermofisher.com) using pub-
lished primers targeting ≈300 bp of the lfb1 gene (2) 
and sequenced the amplicons as previously described 
(3). Leptospira lfb1 sequences are available in GenBank 
under accession nos. MH795484–MH795490 (rodents) 
and MH795482–MH795483 (water).
The prevalence of Leptospira infection in rodents 
was 66.7% (8/12), and we detected Leptospira DNA 
in 40% (2/5) of water samples. Sequencing of the lfb1 
amplicons from both rodent and water samples iden-
tified a single genotype. Phylogenetic analysis using 
Figure. Neighbor-joining phylogenetic tree based of 256 bp of Leptospira lfb1 gene of isolates from South Africa and reference 
sequences. Leptospira sequences collected during this study are labeled according to sample source (rodent, water) and the number 
of sequences indicated. Reference sequences include lfb1 sequences from isolates obtained from human cases of leptospirosis in New 
Caledonia (3). GenBank accession numbers are provided in parentheses. Scale bar indicates nucleotide substitutions per site.
MEGA7 (4) revealed 100% identity to strains isolated 
from humans in New Caledonia and typed as L. in-
terrogans serogroup Icterohaemorrhagiae (Figure) (5), 
a serogroup identified in historical cases from Cape 
Town (6,7).
L. interrogans serogroup Icterohaemorrhagiae, 
traditionally associated with rats, is frequently im-
plicated in fatal leptospirosis and survives for pro-
longed periods in fresh water (8). Therefore, rodent 
infestations, the high prevalence of infected rodents, 
and increased environmental contamination are like-
ly to have contributed to this prison outbreak of hu-
man leptospirosis. To reduce inmate exposure, the 
affected section of the prison was evacuated before 
intensive clean-up and rodent control activities were 
undertaken. Moreover, early referral of inmates with 
nonspecific febrile illness for preemptive treatment of 
leptospirosis was implemented. Thirty serum sam-
ples from symptomatic inmates were referred for Lep-
tospira spp. IgM ELISA and real-time PCR; all tested 
negative, possibly because of the intermittent nature 
of leptospiraemia and the lack of detectable antibod-
ies during early stages of the disease (9). No addition-
al cases of leptospirosis were diagnosed.
We found evidence that rodent infestation and 
contaminated environments within confined settings, 
such as prisons, are risk factors for leptospirosis in hu-
mans, supporting previous findings from an Ecuador 
prison (10). Moreover, the finding that highly patho-
genic Leptospira spp (6,7). continue to circulate in ro-
dents suggests that human leptospirosis may be an 
underreported public health problem in South Africa, 
particularly among persons living in informal settle-
ments, where rodent infestations are common and en-
vironmental conditions favor disease transmission.
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